Relmada Therapeutics, Inc.
RLMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,384 | $1,353 | $1,150 | $3,857 |
| Short-Term Investments | $12,502 | $19,266 | $25,911 | $41,052 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $14,854 | $21,094 | $27,657 | $45,796 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $22 | $22 | $22 | $22 |
| Total NC Assets | $22 | $22 | $22 | $22 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $14,876 | $21,116 | $27,679 | $45,818 |
| Liabilities | – | – | – | – |
| Payables | $1,453 | $1,362 | $1,265 | $4,131 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1,823 | $2,227 | $1,019 | $1,154 |
| Total Curr. Liab. | $5,190 | $5,135 | $5,231 | $10,291 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $221 | $32 | $8 | $4 |
| Total NC Liab. | $221 | $32 | $8 | $4 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $5,411 | $5,167 | $5,239 | $10,296 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $33 | $33 | $33 | $30 |
| Retained Earnings | -$678,399 | -$668,308 | -$658,442 | -$640,882 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $9,466 | $15,949 | $22,440 | $35,522 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $14,876 | $21,116 | $27,679 | $45,818 |
| Net Debt | -$1,384 | -$1,353 | -$1,150 | -$3,857 |